Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.6% of net sales.
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.6% of net sales.
Source: Cofisem - Last Update: 2023-05-06
Key Executives
| Chairman and Chief Executive Officer | |
| Chief Financial Officer | |
| Company Secretary | |
| Human Resources Director | |
| Director Research & Development |
Source: Cofisem - Last Update: 2022-10-03
Key Figures
| Millenium | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Net sales | 24,658,779 | 22,941,540 | 20,703,583 | 20,861,536 | 20,761,678 |
| Cost of sales | 6,000,993 | 5,699,400 | 5,015,472 | 3,889,772 | 3,585,448 |
| Personnal costs | 0 | 0 | 0 | ||
| Operating income | 8,961,208 | 6,745,850 | 7,442,182 | 8,638,580 | 8,972,801 |
| Income tax | 743,801 | 713,529 | 707,655 | 1,157,288 | 1,006,304 |
| Net income | 6,137,762 | 5,203,992 | 5,915,309 | 7,002,661 | 7,338,760 |
| Net consolidated income (Group share) | 6,137,762 | 5,203,992 | 5,915,309 | 7,002,661 | 7,338,760 |
| Fiscal year end | 12.22 | 12.21 | 12.2 | 12.19 | 12.18 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards |
Source: Cofisem - Last Update: 2023-05-06
Shareholder information
| BlackRock, Inc. | |
| The Vanguard Group, Inc. | |
| State Street Corporation |
Source: Cofisem - Last Update: 2023-05-06
Address
Amgen Inc.
1 Amgen Center Drive
CA 91320-1799 Thousand Oaks, California
United States
Phone number: +1 805 447 1000
Fax: +1 805 447 1010
https://investors.amgen.com/
Source: Cofisem - Last Update: 2023-05-06
Please contact MyQuestion.Italy@euronext.com for Company Profile support.